PAPER Wang LJ, He JC, Wang LF, Gu YW, Fan HG, Tian HJ

[Neuroprotective effect of ginsenoside Rb-1 on a rat model of Alzheimer's disease].

Zhonghua Yi Xue Za Zhi. 2020 Aug 18;100(31):2462-2466. PubMed.

PAPER Chen HM, Zhang MM, Wang YL

[Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease].

Zhonghua Yi Xue Za Zhi. 2020 Nov 24;100(43):3397-3401. PubMed.

PAPER Liu J, Cao ZY

[Roles of amyloid-β in the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease should be clarified].

Zhonghua Yi Xue Za Zhi. 2020 Nov 24;100(43):3385-3387. PubMed.

PAPER Chen JY, Liu XY, Xu YS, Fan DS

[Association between rare UBQLN2 variants and amyotrophic lateral sclerosis in Chinese population].

Zhonghua Yi Xue Za Zhi. 2021 Mar 30;101(12):846-850. PubMed.

PAPER Li LJ, Yang J, Yuan YP, Wang YY, Liu XJ, Jiang CY, Xu YM

[Application of skin phosphorylated synuclein in the diagnosis of dementia with Lewy body].

Zhonghua Yi Xue Za Zhi. 2022 Feb 8;102(5):378-381. PubMed.

PAPER Zhang YY, Xin X, Yang CY, Wang XY, Xia T, Wang HY

[The application value of plasma heterogeneous nuclear ribonucleoprotein A2/B1, Aβ42 and P-tau in the preoperative diagnosis of mild cognitive dysfunction].

Zhonghua Yi Xue Za Zhi. 2022 Feb 8;102(5):321-325. PubMed.

PAPER Liu SW, Xie WY, Zhang YC, Zhu JT, Liu CF, Hu H

[Third ventricle width measured by transcranial ultrasound and its diagnostic value in patients with Alzheimer's disease].

Zhonghua Yi Xue Za Zhi. 2022 Apr 5;102(13):948-953. PubMed.

PAPER Liu SW, Li M, Zhu JT, Zhang YC, Wu YH, Liu CF, Hu H

[Correlation of muscle strength with cognitive function and medial temporal lobe atrophy in patients with mild to moderate Alzheimer's disease].

Zhonghua Yi Xue Za Zhi. 2022 Sep 20;102(35):2786-2792. PubMed.

PAPER Yan XM, Li PJ, Li W, Wang XM, Yu S

[Alterations in erythrocytic oligomeric alpha-synuclein in patients with Parkinson's disease and multiple system atrophy].

Zhonghua Yi Xue Za Zhi. 2023 Oct 10;103(37):2933-2939. PubMed.

PAPER Li XG, Liu MS, Cui LY

[Attention should be paid to the importance of genetic testing in clinical practice of amyotrophic lateral sclerosis].

Zhonghua Yi Xue Za Zhi. 2023 Oct 24;103(39):3071-3076. PubMed.

PAPER Gu Q, Chen SF, Chen KL, Huang YY, Ge JJ, Zuo CT, Cui M, Dong Q, Yu JT

[The clinical application value of brain 18F-FDG PET/CT in the diagnostics of Parkinsonian syndromes].

Zhonghua Yi Xue Za Zhi. 2023 Nov 7;103(41):3294-3300. PubMed.

PAPER Chinese Society of Dementia and Cognitive lmpairment, Chinese Society of Nuclear Medicine

[Expert consensus on the application of amyloid-PET imaging in the diagnosis of Alzheimer's disease].

Zhonghua Yi Xue Za Zhi. 2023 Dec 5;103(45):3615-3626. PubMed.

PAPER Xing Y, Qin Q, Wang ZB, Wang DY, Li SY, Sun YW, Jin HM, Wu GS, Cai LJ, Wang XY, Tang Y

[Observation of the consistency between intellectualized and manual-based cognitive assessment tools in the outpatient clinic].

Zhonghua Yi Xue Za Zhi. 2024 Feb 27;104(8):600-607. PubMed.

PAPER Zhang JW, Chen S

[The dilemma and comprehensive assessment for a precise diagnosis of Alzheimer's disease].

Zhonghua Yi Xue Za Zhi. 2024 Jul 30;104(29):2683-2687. PubMed.

PAPER National Health Commission Capacity Building and Continuing Education Center, Chinese Neuroscience Society, Aging Biomarker Consortium, Writing Group for the Chinese Guideline for Clinical Application of Fluid Biomarkers for Alzheimer′s Disease

[Chinese guideline for clinical application of fluid biomarkers for Alzheimer's disease(2024 edition)].

Zhonghua Yi Xue Za Zhi. 2024 Sep 10;104(35):3292-3306. PubMed.